An IGF2BP2-MYBL2-HMGB2 Signaling Axis Promotes Macrophage Immune Evasion in Hepatocellular Carcinoma. [PDF]
Ha JW +5 more
europepmc +1 more source
Urinary Volatile Organic Compounds as Non-Invasive Biomarkers to Distinguish Hepatocellular Carcinoma from Cirrhosis: A Multicentre Diagnostic Accuracy Study. [PDF]
Hussain Y +5 more
europepmc +1 more source
YAP1 induces hepatocellular carcinoma via DNA demethylation rather than by canonical driver gene mutations. [PDF]
Kosaka M +13 more
europepmc +1 more source
miR-139-5p Targets CENPM to Suppress EMT and Malignant Progression of Hepatocellular Carcinoma via Regulating the Akt/mTOR Pathway and β-Catenin Nuclear Translocation. [PDF]
Fan A +11 more
europepmc +1 more source
Transketolase-like 1 potentiates PD-1 blockade in hepatocellular carcinoma by glycolysis to prime dendritic cell lactylation. [PDF]
Cao H +24 more
europepmc +1 more source
Metabolic dysfunction and GZMK<sup>+</sup> CD8<sup>+</sup> T-cell remodeling in hepatocellular carcinoma: an evidence-stratified, hypothesis-generating review. [PDF]
Zhong Q +6 more
europepmc +1 more source
MicroRNA-122 as a regulator and biomarker of liver disease. [PDF]
Ahmadova S +7 more
europepmc +1 more source
The Role of Mitochondrial Dysfunction in Hepatocellular Carcinoma: From Pathogenesis and Drug Resistance to Targeted Therapeutic Strategies. [PDF]
Zhao S +8 more
europepmc +1 more source

